- CA$45.61m
- CA$63.03m
- CA$0.24m
US targets Russia with hundreds of sanctions over Ukraine war, Navalny death (updated)
Motorcycling-Pirro to replace Bastianini at Ducati for Americas GP (updated)
Uzbekistan halts use of Russia's Mir payment cards (updated)
Uzbekistan halts use of Russia's Mir payment cards
Brief: Medmira Receives Patent For Its Unique Quantitative Diagnostic System
Brief: Medmira Provides An Update On The New In Vitro Diagnostic Medical Devices Regulation (Ivdr) In The European Market
Brief: MedMira Receives CE Mark For Multiplo Complete Syphilis Antibody Test
Brief: Medmira Receives The CE Mark For Its Reveal TP (Syphilis) And Starts Clinical Trials In Canada
Brief: Medmira Reports Q3 FY2021 Revenues Of $64,631 Compared To $87,207 In Q3 FY2020
Brief: MedMira Inc Announces Performance Update On World Health Organisation SARS-CoV2 Serology Standards
Brief: Medmira To Seek FDA Authorization For REVEALCOVID-19 Nab-Y and VYRA CoV-2 Tests
Brief: MedMira Inc Announces Development Of Rapid Antibody Test Prototype That Detects Presence Of Neutralizing Antibodies Against Sars-Cov-2 Virus
Brief: MedMira Says New EUA Application To Be Submitted To U.S. FDA In 10 Business Days For Revealcovid-19 Plus Total Antibody Test
Brief: Medmira Inc Says COVID-19 Total Antibody Test Correctly Identified 71 Of 73 Negative Specimens At Over 97% Specificity
Brief: Medmira Announces Exclusive Distribution Partnership With Webb Diagnostic Technologies
Brief: Medmira Announces Progress Update Of Its Revealcovid-19 Total Antibody Test Including CE Mark
Brief: Management Cease Trade Order Update
Brief: Medmira Expects To File Annual Filings Before February 28
Brief: Medmira Says Expects To File Annual Filings Before Feb 28